The rich platelet plasma (RPP) and indiferenciate mesenchimal cells (IMCs), or stem cells, have been widely studied because of their high potential of osteoinduction in bone grafts. However, the utilization of RPP and IMCs must be done following correct methodology of isolation and use. The inappropriate methodology can be a determinant factor of its efficacy on bone grafts and can explain some controversial results of its utilization in bone grafts.
stem cells; platelets; osteoinduction